JP2008542321A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542321A5
JP2008542321A5 JP2008514011A JP2008514011A JP2008542321A5 JP 2008542321 A5 JP2008542321 A5 JP 2008542321A5 JP 2008514011 A JP2008514011 A JP 2008514011A JP 2008514011 A JP2008514011 A JP 2008514011A JP 2008542321 A5 JP2008542321 A5 JP 2008542321A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
monoclonal antibody
fragment
humanized monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008514011A
Other languages
English (en)
Japanese (ja)
Other versions
JP5414271B2 (ja
JP2008542321A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/005194 external-priority patent/WO2006128690A1/en
Publication of JP2008542321A publication Critical patent/JP2008542321A/ja
Publication of JP2008542321A5 publication Critical patent/JP2008542321A5/ja
Application granted granted Critical
Publication of JP5414271B2 publication Critical patent/JP5414271B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008514011A 2005-06-01 2006-05-31 抗il2抗体 Expired - Fee Related JP5414271B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05011845 2005-06-01
EP05011845.4 2005-06-01
PCT/EP2006/005194 WO2006128690A1 (en) 2005-06-01 2006-05-31 Anti-il2 antibodies

Publications (3)

Publication Number Publication Date
JP2008542321A JP2008542321A (ja) 2008-11-27
JP2008542321A5 true JP2008542321A5 (cg-RX-API-DMAC7.html) 2012-08-09
JP5414271B2 JP5414271B2 (ja) 2014-02-12

Family

ID=37025008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008514011A Expired - Fee Related JP5414271B2 (ja) 2005-06-01 2006-05-31 抗il2抗体

Country Status (15)

Country Link
US (1) US7964707B2 (cg-RX-API-DMAC7.html)
EP (1) EP1888644A1 (cg-RX-API-DMAC7.html)
JP (1) JP5414271B2 (cg-RX-API-DMAC7.html)
KR (1) KR101340559B1 (cg-RX-API-DMAC7.html)
CN (1) CN101189265B (cg-RX-API-DMAC7.html)
AU (1) AU2006254333B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0610912A2 (cg-RX-API-DMAC7.html)
CA (1) CA2609234C (cg-RX-API-DMAC7.html)
IL (1) IL187316A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014565A (cg-RX-API-DMAC7.html)
NO (1) NO20076568L (cg-RX-API-DMAC7.html)
NZ (1) NZ563213A (cg-RX-API-DMAC7.html)
RU (1) RU2425054C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006128690A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200709456B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011009704A (es) * 2009-03-16 2011-09-28 Cephalon Australia Pty Ltd Anticuerpos humanizados con actividad anti-tumor.
CA2778552A1 (en) * 2009-11-05 2011-05-12 Cephalon Australia Pty Ltd Treatment of cancer involving mutated kras or braf genes
AU2013243574B2 (en) * 2012-04-03 2017-12-07 Novelmed Therapeutics, Inc Humanized and chimeric anti-factor C3 antibodies and uses thereof
SG10201805706XA (en) 2013-12-12 2018-08-30 Umc Utrecht Holding Bv Immunoglobulin-like molecules directed against fibronectin-eda
HUE064292T2 (hu) 2013-12-26 2024-03-28 Mitsubishi Tanabe Pharma Corp Humán anti-IL-33 semlegesítõ monoklonális antitest
CA2954476C (en) 2014-07-10 2023-09-19 Novartis Ag Immune-stimulating monoclonal antibodies against human interleukin-2
EP3365369A1 (en) 2015-10-23 2018-08-29 Pfizer Inc Anti-il-2 antibodies and compositions and uses thereof
JP6993699B2 (ja) 2016-01-11 2022-02-03 ウニヴェルズィテート・ツューリヒ ヒトインターロイキン-2に対する免疫刺激性ヒト化モノクローナル抗体及びその融合タンパク質
JP7120989B2 (ja) 2016-07-06 2022-08-17 セルジーン コーポレイション 低免疫原性を有する抗体及びその使用
US10858428B2 (en) 2016-09-28 2020-12-08 Xoma (Us) Llc Antibodies that bind interleukin-2 and uses thereof
AU2018271751B2 (en) 2017-05-25 2021-04-01 Institute For Basic Science Anti-human interleukin-2 antibodies and uses thereof
WO2019045075A1 (ja) 2017-08-31 2019-03-07 田辺三菱製薬株式会社 Il-33アンタゴニストを含む子宮内膜症治療剤
MX2021011258A (es) 2019-03-18 2021-12-10 Biontech Cell & Gene Therapies Gmbh Variantes de interleucina-2 (il2) y receptor de interleucina-2 (il2r) para la activacion especifica de celulas efectoras inmunitarias.
JP7245358B2 (ja) 2019-06-10 2023-03-23 山東博安生物技術股▲ふん▼有限公司 抗cd25抗体及びその適用
WO2022207521A1 (en) 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Protease-activated polypeptides
CN113248610B (zh) * 2021-05-14 2022-08-16 厦门柏慈生物科技有限公司 白细胞介素2结合分子、其衍生物、试剂盒及其生产方法和用途
CN119948048A (zh) 2022-09-29 2025-05-06 豪夫迈·罗氏有限公司 蛋白酶活化的多肽
CN115850471B (zh) * 2022-10-13 2026-04-07 深圳市百士通科技开发有限公司 一种抗人il-2单克隆抗体及其应用
CN119661706B (zh) * 2024-01-31 2025-11-28 康立泰生物医药(青岛)有限公司 一种抗人白介素2抗体及其应用
CN118515762B (zh) * 2024-07-23 2024-11-01 北京百普赛斯生物科技股份有限公司 特异性结合il-2的抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19651443A1 (de) * 1996-12-11 1998-06-18 Hoechst Ag Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme
AU2001274939A1 (en) 2000-05-24 2001-12-03 Smith Kline Beecham Corporation Sialoadhesin factor-3 antibodies
GB0013810D0 (en) * 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
BRPI0214168B8 (pt) * 2001-11-14 2021-05-25 Centocor Inc anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
AU2003295471B2 (en) * 2002-11-15 2011-08-25 Genmab A/S Human monoclonal antibodies against CD25
ES2398394T3 (es) * 2003-08-13 2013-03-15 Novartis Vaccines And Diagnostics, Inc. Reactivos peptídicos específicos de prión

Similar Documents

Publication Publication Date Title
RU2458071C2 (ru) Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека
CN108367075B (zh) 4-1bb结合蛋白及其用途
TWI496790B (zh) 介白素-13結合蛋白質
RU2007143996A (ru) Антитела против il2
JP2010534478A5 (cg-RX-API-DMAC7.html)
JP2018519364A5 (cg-RX-API-DMAC7.html)
JP2023134618A5 (cg-RX-API-DMAC7.html)
JP2018183173A5 (cg-RX-API-DMAC7.html)
JP2020514277A5 (cg-RX-API-DMAC7.html)
JP2020513791A5 (cg-RX-API-DMAC7.html)
AU2016293118A1 (en) Antibody molecules which bind CD45
JP2016512551A5 (cg-RX-API-DMAC7.html)
JP2018526981A5 (cg-RX-API-DMAC7.html)
CN105026426A (zh) 血小板衍生生长因子b之特异性抗体及其组合物和用途
JP2013535952A5 (cg-RX-API-DMAC7.html)
JP2008527989A5 (cg-RX-API-DMAC7.html)
AU2016293119A1 (en) Antibody molecules which bind CD79
AU2016369307A1 (en) Multi-specific antibody molecules having specificity for TNF-alpha, IL-17A and IL-17F
RU2013110874A (ru) Антитела против il-18r1 и их применения
TW201107345A (en) Immunoglobulins
JP2020502233A5 (cg-RX-API-DMAC7.html)
JP2010509931A5 (cg-RX-API-DMAC7.html)
JP2011518857A5 (cg-RX-API-DMAC7.html)
US10640576B2 (en) Cell engaging binding molecules
TW201134489A (en) Basigin binding proteins